Anal melanoma treatment: how care is planned

Surgery may control a removable local tumour, while immunotherapy, targeted medicines or radiotherapy may address disease risk or spread. The order and purpose of these options differ from person to person.

Before recommending treatment, the team confirms the diagnosis, maps the tumour and checks lymph nodes and distant organs. Pathology and molecular testing may reveal tumour features that affect medicine choices. Your fitness for treatment, symptoms and priorities are part of the decision.

Local excision removes the tumour with a margin while aiming to preserve anal function when feasible. More extensive surgery may be considered if local clearance cannot otherwise be achieved. The team weighs local control against recovery, continence and the possibility of a stoma, and should explain these trade-offs clearly.

Ask for the aim of every proposed treatment: removing visible disease, reducing recurrence risk, controlling spread or easing symptoms. Discuss alternatives, likely side effects, recovery needs and how response will be checked. A specialist nurse, stoma nurse, dietitian or pain team may help before problems become difficult.

Take medicines exactly as directed and report immune-treatment symptoms early, including new diarrhoea, rash, cough, marked fatigue, headache or yellowing of the skin. Do not start supplements or topical remedies without checking for interactions or effects on healing.

Call the team promptly for fever, worsening wound redness, pus, uncontrolled vomiting, persistent diarrhoea, increasing anal pain, new bleeding or difficulty passing stool. After systemic therapy, new breathing trouble, confusion, severe weakness or reduced urine output also needs urgent assessment.

Use emergency services for heavy bleeding, collapse, severe breathing difficulty, a seizure or sudden weakness on one side. Treatment side effects can evolve between appointments, so follow the personalised contact instructions provided by the oncology service.

Ask whether the plan has been reviewed by specialists in mucosal melanoma and colorectal cancer, why a particular operation or medicine is favoured, and how it may affect bowel control. Clarify what response would look like, when reassessment occurs and what options remain if the first approach does not control the disease.